Literature DB >> 31038840

Validation of the olfactory disorders questionnaire for English-speaking patients with olfactory disorders.

Lorna Langstaff1, Nisha Pradhan2, Allan Clark3, Duncan Boak4, Mahmoud Salam5, Thomas Hummel6, Carl M Philpott1,3.   

Abstract

OBJECTIVES: To adapt the existing German language olfactory disorders questionnaire for use with English-speaking patients. To validate the adapted version for routine clinical use.
DESIGN: The translated version of the original German questionnaire was revised with a patient and a clinician to reflect British language and culture. Patients attending an olfactory dysfunction clinic were recruited to perform the adapted questionnaire on two occasions at least 1 month apart. Additional online participants completed the questionnaire via the charity Fifth Sense. MAIN OUTCOME MEASURES: Retest reliability of the English olfactory disorders questionnaire (eODQ) in affected patients including potential for redundancy in any of the included questions. Correlation of eODQ scores with Sniffin' Sticks scores.
RESULTS: Eighty-seven patients reporting olfactory dysfunction were recruited and had a mean age of 48 with 35% of them being male; 50 datasets were available for analysis. A total of 957 members of the charity entered responses into the online questionnaire; 699 responses could be scored with participants' mean age of 55 years and with 69% reporting as female. The eODQ score and Sniffin' Sticks threshold, discrimination and identification score at timepoint 1 were correlated to assess for concurrent validity, (r = -0.15, P = 0.17) and showed no significant correlation. Female participants had a significantly higher mean total eODQ score than men, 55.75 compared to 52.28 (P = 0.001). The average score was 54.7 (SD 13.5) with a range from 26 to 87. The internal consistency of the questionnaire was good with a Cronbach's alpha of 0.90 (confidence intervals 0.89, 0.91).
CONCLUSIONS: The results of this study support the use of the eODQ in a native English-speaking population and highlight the different distinctions between "objective" testing of olfaction with the Sniffin' Sticks test, and the patient reported impact of olfactory dysfunction on daily life. These two types of assessment can be easily administered in an outpatient setting and used in the assessment and management of olfactory dysfunction.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  Nasal; anosmia; language; odour; olfaction; quality of life; reliability; smell; taste

Year:  2019        PMID: 31038840     DOI: 10.1111/coa.13351

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  8 in total

1.  The study of olfactory dysfunction in SARS-CoV-2 variants.

Authors:  Luigi A Vaira; Paolo Boscolo-Rizzo; Emily Bui Quoc; Patrick Bandekela; Sven Saussez; Jerome R Lechien
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-16       Impact factor: 3.236

2.  Effect of early olfactory training on olfactory recovery after nasal endoscopy in patients with chronic rhinosinusitis and olfactory impairment.

Authors:  Jinfeng Zhang; Yong Feng; Wei Liu; Lei He; Xiaocheng Qiao
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

3.  Barriers to effective health care for patients who have smell or taste disorders.

Authors:  Stephen Ball; Duncan Boak; Joanne Dixon; Sean Carrie; Carl M Philpott
Journal:  Clin Otolaryngol       Date:  2021-06-15       Impact factor: 2.729

4.  TaSCA, an Agile Survey on Chemosensory Impairments for Self-Monitoring of COVID-19 Patients: A Pilot Study.

Authors:  Carla Mucignat-Caretta; Patrizia Bisiacchi; Gian Luigi Marcazzan; Arianna Calistri; Cristina Parolin; Angelo Antonini
Journal:  Front Neurol       Date:  2021-02-24       Impact factor: 4.003

5.  Predictive significance of the questionnaire of olfactory disorders-negative statements for olfactory loss in patients with chronic rhinosinusitis.

Authors:  Dawei Wu; Yongxiang Wei; Fan Yuan
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-19       Impact factor: 3.236

6.  COCOS trial: COrticosteroids for COVID-19-induced loss of Smell-protocol for a single-centred, double-blind, randomised, placebo-controlled trial.

Authors:  Emma J A Schepens; Wilbert M Boek; Sanne Boesveldt; Inge Stegeman; Robert J Stokroos; Digna M A Kamalski
Journal:  BMJ Open       Date:  2022-08-10       Impact factor: 3.006

7.  Validity and reliability of a french version of the olfactory disorders questionnaire.

Authors:  Jérôme R Lechien; Luigi A Vaira; Serge D Le Bon; Roxane Geerts; Paolo Boscolo-Rizzo; Sven Saussez
Journal:  J Otolaryngol Head Neck Surg       Date:  2022-10-01

8.  Is loss of sense of smell a diagnostic marker in COVID-19: A systematic review and meta-analysis.

Authors:  John Rocke; Claire Hopkins; Carl Philpott; Nirmal Kumar
Journal:  Clin Otolaryngol       Date:  2020-09-16       Impact factor: 2.729

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.